Vir Biotechnology, Inc.: capex
| Value | {"amount": 1872000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-03-31 |
| Status | current |
| Entity | Vir Biotechnology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:28:03.755260+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8b362324-31ef-4214-82c9-820686fe6618
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-24-020299Retrieved: 2026-08-19T17:28:03.755260+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001706431/capex/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8b362324-31ef-4214-82c9-820686fe6618
History
- no predecessors — first report